OEHME; Felix

Patent Applications and Registrations

Patent applications and USPTO patent grants for OEHME; Felix.The latest application filed is for "substituted dihydropyrazolones for treating cardiovascular and hematological diseases".

Company Profile

0.15.15

OEHME; Felix - Wuppertal DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Substituted Dihydropyrazolones For Treating Cardiovascular And Hematological Diseases App 20160229858 - THEDE; Kai ; et al.	2016-08-11
Substituted dihydropyrazolones for treating cardiovascular and hematological diseases Grant 9,168,249 - Thede , et al. October 27, 2	2015-10-27
4-(pyridin-3-yl)-2(pyridin-2yl)-1,2-dihydro-3H-pyrazol-3-one derivatives as specific HIF-pyrolyl-4-hydroxylase inhibitors for treating cardiovascular and haematological diseases Grant 9,085,572 - Flamme , et al. July 21, 2	2015-07-21
Substituted Dihydropyrazolones For Treating Cardiovascular And Hematological Diseases App 20150148381 - THEDE; Kai ; et al.	2015-05-28
Substituted dihydropyrazolones for treating cardiovascular and hematological diseases Grant 8,987,261 - Thede , et al. March 24, 2	2015-03-24
Substituted dihydropyrazolones for treating cardiovascular and hematological diseases Grant 8,653,111 - Thede , et al. February 18, 2	2014-02-18
Substituted Dihydropyrazolones For Treating Cardiovascular And Hematological Diseases App 20140031329 - THEDE; Kai ; et al.	2014-01-30
Substituted dipyridyl-dihydropyrazolones and use thereof Grant 8,609,698 - Thede , et al. December 17, 2	2013-12-17
Substituted dihydropyrazolones and use thereof as HIF-prolyl-4-hydroxylase inhibitors Grant 8,524,699 - Thede , et al. September 3, 2	2013-09-03
Substituted dihydropyrazolones for treating cardiovascular and hematological diseases Grant 8,389,520 - Thede , et al. March 5, 2	2013-03-05
Substituted Imidazopyrimidines And Triazolopyrimidines App 20120322772 - FLAMME; Ingo ; et al.	2012-12-20
Substituted Dihydropyrazolones And Use Thereof As Hif-prolyl-4 -hydroxylase Inhibitors App 20120264704 - Thede; Kai ; et al.	2012-10-18
Dipyridyl-dihydropyrazolones and their use Grant 8,252,817 - Flamme , et al. August 28, 2	2012-08-28
Substituted Dihydropyrazolones For Treating Cardiovascular And Hematological Diseases App 20120121727 - THEDE; Kai ; et al.	2012-05-17
Substituted Dihydropyrazolones For Treating Cardiovascular And Hematological Diseases App 20100305085 - Thede; Kai ; et al.	2010-12-02
Substituted Dipyridyl-dihydropyrazolones And Use Thereof App 20100093803 - Thede; Kai ; et al.	2010-04-15
Dipyridyl-dihydropyrazolones and their use App 20100035906 - Flamme; Ingo ; et al.	2010-02-11
Chimeric Kunitz Domains and their Use App 20090170766 - Oehme; Felix ; et al.	2009-07-02
Regulation of novel human asparagine-hydroxylases App 20070117142 - Flamme; Ingo ; et al.	2007-05-24
Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (PARS) Grant 7,125,995 - Albrecht , et al. October 24, 2	2006-10-24
Regulation of novel human prolyl 4-hydroxylases App 20060110769 - Ramakrishnan; Shyam ; et al.	2006-05-25
Substituted alkyl uracils and thereof App 20050159431 - Albrecht, Barbara ; et al.	2005-07-21
Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (pars) App 20050075347 - Albrecht, Barbara ; et al.	2005-04-07
Substituted amidoalkyl-uracils and their use Grant 6,649,618 - Harter , et al. November 18, 2	2003-11-18
Substituted amidoalkyl-uracils and their use App 20030022905 - Harter, Michael ; et al.	2003-01-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.